Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05252390
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:00.216624+00:00
Published At
2025-11-06T00:00:00+00:00
Record Updated At
2025-11-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Solid Tumor", "Ovarian Cancer", "Ovary Cancer", "Cancer of Ovary", "Cancer of the Ovary", "Ovary Neoplasm", "Pancreatic Cancer", "Pancreas Cancer", "Cancer of Pancreas", "Cancer of the Pancreas", "Pancreas Neoplasm", "Prostate Cancer", "Prostatic Cancer", "Cancer of Prostate", "Cancer of the Prostate", "Prostate Neoplasm", "Castrate Resistant Prostate Cancer", "Castration Resistant Prostatic Cancer", "Castration Resistant Prostatic Neoplasms", "Triple-negative Breast Cancer", "Triple Negative Breast Cancer", "Triple Negative Breast Neoplasms", "Breast Cancer", "Breast Carcinoma", "Cancer of Breast", "Cancer of the Breast", "Breast Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-06"
protocolSection.identificationModule.nctId
"NCT05252390"
protocolSection.identificationModule.officialTitle
"Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Solid Tumor (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Ovary Cancer (protocolSection.conditionsModule.conditions)
  • Cancer of Ovary (protocolSection.conditionsModule.conditions)
  • Cancer of the Ovary (protocolSection.conditionsModule.conditions)
  • Ovary Neoplasm (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Pancreas Cancer (protocolSection.conditionsModule.conditions)
  • Cancer of Pancreas (protocolSection.conditionsModule.conditions)
  • Cancer of the Pancreas (protocolSection.conditionsModule.conditions)
  • Pancreas Neoplasm (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Prostatic Cancer (protocolSection.conditionsModule.conditions)
  • Cancer of Prostate (protocolSection.conditionsModule.conditions)
  • Cancer of the Prostate (protocolSection.conditionsModule.conditions)
  • Prostate Neoplasm (protocolSection.conditionsModule.conditions)
  • Castrate Resistant Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Castration Resistant Prostatic Cancer (protocolSection.conditionsModule.conditions)
  • Castration Resistant Prostatic Neoplasms (protocolSection.conditionsModule.conditions)
  • Triple-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Triple Negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Triple Negative Breast Neoplasms (protocolSection.conditionsModule.conditions)
  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Cancer of Breast (protocolSection.conditionsModule.conditions)
  • Cancer of the Breast (protocolSection.conditionsModule.conditions)
  • Breast Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.